(1)
Kumar, A. H. .; George, M. Evaluating the Chrono-Pharmacology of Icosapent Ethyl to Assess Its Therapeutic Efficacy in Reducing Hypertriglyceridemia Associated Cardiovascular Events. BEMS Reports 2021, 5, 26-28.